Magnetic Resonance in Medicine · 2001 · 57 citations · 19 references
MedicineNeuroscienceOncologyDiagnostic ImagingMagnetic Resonance BiophysicsNeuro-oncologyGlioblastomaMagnetic Resonance ImagingMagnetic Resonance Of LipidsMagnetic Resonance SpectroscopyTumor Imaging1D Proton Nuclear Magnetic Resonance SpectroscopyDifferentiationIn Vivo Nmr SpectroscopyIn Vivo StudiesLipid Nuclear Magnetic Resonance SpectroscopyMagnetic ResonanceNuclear Magnetic Resonance Spectroscopy Data AnalysisNuclear Resonances
Focal brain lesions can be associated with proton magnetic resonance spectra (1H-MRS)-detectable mobile lipids, reflecting severe tissue degradation and necrosis. However, advanced fitting procedures, such as the LCModel, fail to adequately fit spectra in the presence of lipid resonances. To overcome this, different approaches to generate lipid model spectra were compared using a phantom, real in vivo data, and simulated data. Twenty-six in vivo short-echo time (TE) 1H-MRS from 21 malignant gliomas, four infections, and one ischemia were analyzed to evaluate the performance of the modified LCModel fit. Adding simulated aliphatic resonances at 1.3 and 0.9 ppm improved the overall fitting quality remarkably and allowed good separation of lactate and alanine. Also, a better differentiation of glioblastomas and anaplastic gliomas was achieved. In conclusion, we propose a simple way to efficiently include lipid resonances in the LCModel, allowing a better fit of in vivo short-TE 1H-MRS, and demonstrate the diagnostic potential of quantitative assessment of mobile lipids in brain tumors.
19
Human brain tumors: assessment with in vivo proton MR spectroscopy.
Ott D, Jürgen Hennig, Thomas Ernst · Radiology · 1993 · 291 citations
Medicine, Neuroscience, Oncology +16